Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

PURPOSE: Current prognostic tools in myelofibrosis (MF) fail to identify patients at the highest risk of death and are limited by their applicability only to the time of diagnosis. We aimed to define an accelerated phase (AP) in MF by characterizing disease features that can identify patients with m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Tam, Constantine S., Kantarjian, Hagop, Cortes, Jorge, Lynn, Alice, Pierce, Sherry, Zhou, Lingsha, Keating, Michael J., Thomas, Deborah A., Verstovsek, Srdan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2009
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979081/
https://ncbi.nlm.nih.gov/pubmed/19786661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.8833
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller